Skip to main content

GEODE CAPITAL MANAGEMENT, LLC

Position in AKBA — Akebia Therapeutics, Inc.

CIK 1214717 BOSTON, MA

Position in AKBA

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$8,968,630
-$1,137,624 QoQ
Shares Held
6,452,252
+2.8% QoQ
Ownership
2.33%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AKBA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $4,604,584,627 across 67 Drug Manufacturers - Specialty & Generic names. AKBA ranks #32 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AKBA

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $8,968,630 6,452,252
2025-12-31 $10,106,254 6,277,177
2025-09-30 $16,884,916 6,184,951
2025-06-30 $22,111,026 6,074,458
2025-03-31 $9,659,020 5,030,740
2024-12-31 $9,110,680 4,795,095
2024-09-30 $6,275,892 4,754,464
2024-06-30 $4,627,017 4,536,292
2024-03-31 $3,328,673 1,818,947
2023-12-31 $2,234,095 1,801,690
2023-09-30 $1,965,672 1,724,274
2023-06-30 $1,622,273 1,772,977
2023-03-31 $942,198 1,682,498
2022-12-31 $970 1,682,498
2022-09-30 $512,496 1,621,825
2022-06-30 $570,939 1,617,393
2022-03-31 $2,263,680 3,152,758
2021-12-31 $7,250,055 3,207,989
2021-09-30 $9,302,235 3,229,943
2021-06-30 $11,076,851 2,922,652
2021-03-31 $8,796,961 2,598,807
2020-12-31 $6,228,798 2,224,571
2020-09-30 $5,413,110 2,156,618
2020-06-30 $28,541,207 2,101,709
2020-03-31 $13,831,725 1,824,766